MCK
McKesson·NYSE
--
--(--)
--
--(--)
MCK fundamentals
McKesson (MCK) Revenue Breakdown: Q3 2026 Business & Regional Performance
McKesson (MCK) reported total revenue of 106.16B USD in Q3 2026, with its core business segment North American Pharmaceutical contributing 83.20%. Regionally, United States remained the largest market, accounting for 84.64% of total revenue. Explore McKesson's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
McKesson (MCK) reported total revenue of 106.16B USD in Q3 2026, with its core business segment North American Pharmaceutical contributing 83.20%. Regionally, United States remained the largest market, accounting for 84.64% of total revenue. Explore McKesson's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did McKesson's management provide for the next earnings period?What is the market's earnings forecast for McKesson next quarter?What factors drove the changes in McKesson's revenue and profit?What is McKesson's latest dividend and current dividend yield?What does McKesson do and what are its main business segments?What is the revenue and EPS growth rate for McKesson year over year?Did McKesson beat or miss consensus estimates last quarter?What is McKesson's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
